Acorah Software Products - Accounts Production 15.0.600 false true 31 May 2023 1 June 2022 false true No description of principal activity 1 June 2023 31 May 2024 31 May 2024 11354301 Miss C Thompson iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11354301 2023-05-31 11354301 2024-05-31 11354301 2023-06-01 2024-05-31 11354301 frs-core:CurrentFinancialInstruments 2024-05-31 11354301 frs-bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 11354301 frs-bus:FilletedAccounts 2023-06-01 2024-05-31 11354301 frs-bus:Micro-entities 2023-06-01 2024-05-31 11354301 frs-bus:AuditExempt-NoAccountantsReport 2023-06-01 2024-05-31 11354301 frs-bus:Director1 2023-06-01 2024-05-31 11354301 2022-05-31 11354301 2023-05-31 11354301 2022-06-01 2023-05-31 11354301 frs-core:CurrentFinancialInstruments 2023-05-31
Registered number: 11354301
CMT PHARMA LTD
Unaudited Financial Statements
For The Year Ended 31 May 2024
Tax Birmingham SW Ltd
Balance Sheet
Registered number: 11354301
2024 2023
£ £
Current assets 8,574 9,432
Creditors: Amounts Falling Due Within One Year (7,319 ) (4,480 )
NET CURRENT ASSETS 1,255 4,952
TOTAL ASSETS LESS CURRENT LIABILITIES 1,255 4,952
NET ASSETS 1,255 4,952
CAPITAL AND RESERVES 1,255 4,952

Notes

1. General Information
CMT PHARMA LTD is a private company, limited by shares, incorporated in England & Wales, registered number 11354301 . The registered office is 54 Lightwoods Road, Smethwick, B67 5BD.
2. Average Number of Employees
Average number of employees, including directors, during the year was:
2024 2023
Office and administration 1 1
1 1
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Miss C Thompson
Director
23/08/2024